{"product_id":"igamad-jeringa-300mcg-2ml-con-1-inmunoglobulina-humana-anti-d","title":"Igamad Syringe 300Mcg 2Ml With 1 (Human Anti-D Immunoglobulin)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eImmunoglobulins\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eHuman Anti-D Immunoglobulin\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eIgamad\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eHuman Anti-D Immunoglobulin\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e300 mcg in 2 ml syringe\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eGrifols\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eIgamad is a medication indicated for the prophylaxis of hemolytic disease of the newborn due to Rh incompatibility. It is also used in patients with conditions that pose a risk of sensitization to Rh antigens, as well as in the management of clinical situations where it is necessary to prevent the formation of anti-Rh antibodies. Specific indications include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eProphylaxis in Rh-negative pregnant women with Rh-positive fetuses.\u003c\/li\u003e\n    \u003cli\u003eTreatment in cases of maternal-fetal hemorrhage.\u003c\/li\u003e\n    \u003cli\u003ePrevention of hemolytic disease in neonates.\u003c\/li\u003e\n    \u003cli\u003eTherapy in blood transfusion situations where there is a risk of Rh sensitization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Igamad syringe contains 300 mcg of human anti-D immunoglobulin, in a sterile, ready-to-use solution. Excipients are: sodium chloride, citric acid, and water for injection.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eIgamad is contraindicated in patients with known hypersensitivity to human immunoglobulins or any of the components of the formula. It should not be administered to individuals with a history of thrombocytopathies or thrombosis associated with immunoglobulin administration.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of allergic reactions to blood products. Patients should be monitored during administration, especially with the first doses. Additionally, the risk of transmitting infectious agents should be considered, although rigorous donor selection and product processing methods have been followed.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in refrigeration between 2°C and 8°C. Do not freeze. Keep out of reach of children. Once opened, use immediately and do not store for more than 24 hours.\u003c\/p\u003e\n\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e\n\u003cp\u003ePrescription is required for its sale.\u003c\/p\u003e","brand":"Grifols","offers":[{"title":"Default Title","offer_id":45848305860833,"sku":"7501764340669","price":4292.31,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/7501764340669_b50694a6-82b1-4b56-a73b-8e0bdfc5436e.jpg?v=1744677818","url":"https:\/\/wecarepharma.mx\/en\/products\/igamad-jeringa-300mcg-2ml-con-1-inmunoglobulina-humana-anti-d","provider":"WeCare Pharma","version":"1.0","type":"link"}